COMMUNIQUÉS West-GlobeNewswire

BioTelemetry, Inc. Acquires Sweden-based ADEA Medical AB and Expands International Service Offering
24/07/2019
MALVERN, Pa., July 24, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of [...]
Novan’s Drug Substance Demonstrates Inhibition of HPV-18 Virus Production
24/07/2019
Preclinical data published in Antiviral Research Study conducted by Drs. N.S. Banerjee, L.T. Chow and T.R. Broker at The University of Alabama at Birmingham Findings reinforce anti-viral mechanism of action for Novan’s [...]
Ziopharm Oncology Names Sath Shukla as Chief Financial Officer
24/07/2019
Joins from Vertex Pharmaceuticals; Served as global Head of Corporate Finance BOSTON, July 24, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP), a clinical stage immuno- [...]
Foamix Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 8
24/07/2019
REHOVOT, Israel, and BRIDGEWATER, N.J., July 24, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix”), a clinical-stage pharmaceutical company that specializes in developing and [...]
Miragen Therapeutics to Report Second Quarter 2019 Financial Results and Host a Conference Call on August 7th
24/07/2019
BOULDER, Colo., July 24, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, [...]
HTG Molecular Diagnostics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Tuesday, August 6
24/07/2019
TUCSON, Ariz., July 24, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial [...]
Surgery Partners, Inc. Announces Second Quarter 2019 Earnings Release Date and Conference Call Details
24/07/2019
NASHVILLE, Tenn., July 24, 2019 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that the Company will release its [...]
Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Acute Myeloid Leukemia
24/07/2019
NEW YORK, July 24, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for Lead Immuno-oncology Product Candidate, THOR-707
24/07/2019
SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, announced today it has opened [...]
Chembio Diagnostics to Report Second Quarter 2019 Financial Results on August 6, 2019
24/07/2019
MEDFORD, N.Y., July 24, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial [...]
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
24/07/2019
BOSTON, July 24, 2019 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]
NeuBase Therapeutics Appoints Danith Ly, Ph.D. as Chief Scientific Officer
24/07/2019
Dr. Ly is a leader in the field of peptide nucleic acids and the primary inventor of NeuBase’s proprietary PATrOL™ platform PITTSBURGH, July 24, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“ [...]
Cannabis Suisse Corp. is Happy to Announce the Launching of a New Product in Our Retail Brand Alpine Cannabis
24/07/2019
ALPINE CANNABIS CBD PURE BASE: BOOST YOUR E-LIQUIDS Dietikon, Switzerland, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Alpine Cannabis CBD Pure Base is an e-liquid for electronic cigarettes. It’s an amazing [...]
Julie Stephenson Joins BioSig as Senior Director of Clinical Affairs
24/07/2019
Seasoned electrophysiology professional is the latest addition to the Company’s growing team Westport, CT, July 24, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company [...]
Obalon Announces Second Quarter 2019 Financial Results
24/07/2019
SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Strongbridge Biopharma plc to Host Second Quarter 2019 Financial Results Conference Call on July 31, 2019
24/07/2019
DUBLIN, Ireland and TREVOSE, Pa., July 24, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Microbot Medical Receives Notice of Allowance from the Israel Patent Office for a Patent Application covering a System for Reducing Dialysis Shunt Stenosis
24/07/2019
HINGHAM, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- As it continues to expand and diversify its Intellectual Property (IP) portfolio, Microbot Medical (Nasdaq: MBOT) announced that it has received a Notice of Allowance [...]
T2 Biosystems Announces 2019 Second Quarter Financial and Operational Results Release and Conference Call Date
24/07/2019
LEXINGTON, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, announced [...]
Kura Oncology’s Menin-MLL Inhibitor KO-539 Receives Orphan Drug Designation from FDA for Treatment of Acute Myeloid Leukemia
24/07/2019
SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that the U.S. [...]

Pages